N

New Horizon Research Group | Cullman Research Center

Research site
(Unclaimed)
Location
909 Graham Street Suite D, Cullman, Alabama, United States of America
Site insights

Top conditions

Chronic Obstructive Pulmonary Disease (1 trial)

Inflammation (1 trial)

Lung Diseases (1 trial)

Gastroesophageal Reflux (1 trial)

Human Influenza (1 trial)

Top treatments

Dupilumab
Vonoprazan

Parent organization

This site is a part of New Horizon Research Group

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 3
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation (NOTUS)

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

This study includes 3 parts: Parts A, B, and C. The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1010 seasonal influenz...

Active, not recruiting
Seasonal Influenza
Biological: Licensed Quadrivalent Inactivated Seasonal Influenza Vaccine
Biological: mRNA-1010

Trial sponsors

Moderna logo

Moderna (1 trial)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems